Canada markets open in 6 hours 30 minutes

Bionano Genomics, Inc. (BNGO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.8000-0.0300 (-1.64%)
At close: 04:00PM EDT
1.8400 +0.04 (+2.22%)
After hours: 07:57PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 530.96M
Enterprise Value 354.38M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)22.25
Price/Book (mrq)1.86
Enterprise Value/Revenue 15.19
Enterprise Value/EBITDA -3.40

Trading Information

Stock Price History

Beta (5Y Monthly) 2.16
52-Week Change 3-64.71%
S&P500 52-Week Change 3-15.36%
52 Week High 36.2800
52 Week Low 31.1600
50-Day Moving Average 32.3676
200-Day Moving Average 32.1188

Share Statistics

Avg Vol (3 month) 37.77M
Avg Vol (10 day) 34.28M
Shares Outstanding 5290.14M
Implied Shares Outstanding 6N/A
Float 8284.54M
% Held by Insiders 11.91%
% Held by Institutions 128.80%
Shares Short (Sept 14, 2022) 440.99M
Short Ratio (Sept 14, 2022) 45.99
Short % of Float (Sept 14, 2022) 414.14%
Short % of Shares Outstanding (Sept 14, 2022) 414.13%
Shares Short (prior month Aug 14, 2022) 439.14M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Jun 29, 2022


Profit Margin 0.00%
Operating Margin (ttm)-471.57%

Management Effectiveness

Return on Assets (ttm)-20.27%
Return on Equity (ttm)-33.56%

Income Statement

Revenue (ttm)23.32M
Revenue Per Share (ttm)0.08
Quarterly Revenue Growth (yoy)73.00%
Gross Profit (ttm)3.87M
EBITDA -103.12M
Net Income Avi to Common (ttm)-105.81M
Diluted EPS (ttm)-0.3280
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)187.34M
Total Cash Per Share (mrq)0.65
Total Debt (mrq)10.76M
Total Debt/Equity (mrq)3.78
Current Ratio (mrq)7.75
Book Value Per Share (mrq)0.98

Cash Flow Statement

Operating Cash Flow (ttm)-106.43M
Levered Free Cash Flow (ttm)-50.65M